Metropolitan Life Insurance CO Imago Bio Sciences, Inc. Transaction History

Metropolitan Life Insurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2023	BUY	$15.03 - $35.96 $25,656 - $61,383	1,707 New	1,707 $61.4 Million
Q4 2022 Mar 30, 2023	BUY	$15.03 - $35.96 $3,517 - $8,414	234 Added 15.89%	1,707 $61,000
Q4 2022 Feb 15, 2023	BUY	$15.03 - $35.96 $3,517 - $8,414	234 Added 15.89%	1,707 $61,000
Q3 2022 Jun 14, 2023	BUY	$14.15 - $19.5 $20,842 - $28,723	1,473 New	1,473 $22.2 Million
Q2 2022 Jun 20, 2023	BUY	$11.81 - $20.92 $17,396 - $30,815	1,473 New	1,473 $19,000
Q1 2022 Jun 20, 2023	BUY	$16.97 - $25.0 $24,996 - $36,825	1,473 New	1,473 $28,000
Q1 2022 Mar 30, 2023	SELL	$16.97 - $25.0 $3,970 - $5,850	-234 Reduced 13.71%	1,473 $28,000
Q1 2022 May 12, 2022	BUY	$16.97 - $25.0 $24,996 - $36,825	1,473 New	1,473 $28,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.